# FDA Inspection 1195625 - CKD Bio Corporation - November 18, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/ckd-bio-corporation/65a59b39-c178-4c5b-b52e-e4d5e1a805b5
Source feed: FDA_Inspections

> FDA Inspection 1195625 for CKD Bio Corporation on November 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195625
- Company Name: CKD Bio Corporation
- Inspection Date: 2022-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1299998 - 2025-11-07](https://www.globalkeysolutions.net/records/fda_inspections/ckd-bio-corporation/dc087a7c-e9fb-4cfd-884d-fd633f8e6cbb)
- [FDA Inspection 1299998 - 2025-11-07](https://www.globalkeysolutions.net/records/fda_inspections/ckd-bio-corporation/c75facee-7caf-45a8-b462-d021be50f43a)
- [FDA Inspection 1299998 - 2025-11-07](https://www.globalkeysolutions.net/records/fda_inspections/ckd-bio-corporation/fa04f4a8-5d50-47d7-894d-22a66733049b)
- [FDA Inspection 1299998 - 2025-11-07](https://www.globalkeysolutions.net/records/fda_inspections/ckd-bio-corporation/ac41a297-edca-46d0-aac5-3532895254ef)
- [FDA Inspection 1287766 - 2023-09-15](https://www.globalkeysolutions.net/records/fda_inspections/ckd-bio-corporation/35192101-1bde-4c1a-8f6d-2c46114421e9)

Company: https://www.globalkeysolutions.net/companies/ckd-bio-corporation/98546623-d2d2-4506-8f8a-f1f96339ffc2

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c